Henry McCusker, Regenerative Medicine Investors (11/16/15)
"Mesoblast Ltd. said it expects to raise about $63.8M (CA$95.8M) from the initial public offering, excluding underwriting discounts, commissions and expenses associated with the equity issue. The company will use the proceeds to fund its clinical trial programs, research and development, manufacturing requirements and general administrative expenses. . .the NASDAQ float has brought in enough cash to give Mesoblast '18 months of runway' to fund the final stages of its key clinical trials."
Henry McCusker, Regenerative Medicine Investors (11/16/15)...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
-0.040(3.76%) |
Mkt cap ! $1.170B | |||
| Open | High | Low | Value | Volume |
| $1.07 | $1.07 | $1.01 | $13.19M | 12.81M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 61090 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 239558 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |